AMR Conference Program

Program of the 9th AMR Conference | 25 – 26 February 2025

25 February 2025 Congress Center 2nd floor

09:00 – 10:30 | Pre-conference workshop | Room Sydney

Moderator: Ursula Theuretzbacher, Center for Anti-Infective Agents

Speakers:
Caterina Bissantz, F. Hoffmann-La Roche Ltd
Marc Engelhardt, Basilea Pharmaceutica International Ltd

Jointly organized by

08:45 – 10:30 | General Assembly | Room Osaka/Samarkand

Open only to members of the BEAM Alliance

11:00 – 12:00 | Plenary session | Room Sydney

Moderator: Marc Gitzinger, BioVersys AG & BEAM Alliance

Speakers:
Kevin Outterson, CARB-X
Katie Young, World Economic Forum
Abdulrahman Al Mohana, Public Health Agency of Saudi Arabia 
Molly Moss, United Nations Foundation

More speakers to be announced

12:00 – 13:30 | Lunch break

13:30 – 14:30 | Plenary session | Room Sydney

Moderator: N.N.

Speakers:
Abi Manesh, Christian Medical College Vellore
Nour Shamas, WHO Task Force of AMR Survivors
Olga Tosas Auguet, World Health Organization

More speakers to be announced

15:00 – 16:00 | Parallel sessions

Room Sydney

Moderator: Christoph Dehio, NCCR AntiResist

Speakers:
Sebastian Hiller, University of Basel
Yuping Li, University of Basel
Rolf Müller, Helmholtz Institute for Pharmaceutical Research Saarland

Organized by

Room Singapore

Moderator: Jens Hellwage, InfectoGnostics

Speakers:
Stéphane Gavoille, Molsid
Richard Grohs, Leibniz Institute of Photonic Technology

More speakers to be announced

Organized by

Room Osaka/Samarkand

Moderator: Ingrid Wanninger, HYpharm GmbH

Speakers:
Bernhard Krismer, University of Tübingen
Stefan Hagel, University of Jena
Elda Righi, Guy’s and St Thomas’ NHS Foundation Trust
Radu Botgros, European Medicines Agency

16:00 – 16:30 | Poster presentations

16:30 – 17:30 | Parallel sessions

Room Sydney

Moderator: Markus Zeitlinger, Medical University of Vienna

Speakers:
Alasdair MacGowan, North Bristol NHS Trust
Anouk Muller, Haaglanden Medical Centre
Zhixia Yan, U.S. Food & Drug Administration

Room Singapore

Moderator: N.N.

Speakers to be announced

Room Osaka/Samarkand

Moderator: Erin Sparrow, World Health Organization

Speakers:
Tobi Nagel, Phages for Global Health
Megan Carey, IAVI
Usman Nakakana, Bill and Melinda Gates Foundation
Leander Grode, Serum Life Sciences Europe

18:00 – 19:30 | Pitch session | Room Sydney

Moderator: N.N.

Running order of pitching companies to be announced

Hosted by

19:30 – 21:00 | Evening reception

26 February 2025 Congress Center 2nd floor

08:30 – 09:30 | Plenary session | Room Sydney

Moderator: Erin Duffy, CARB-X

Speakers:
Adam Johnson, Centauri Therapeutics
Chandrasekhar Nair, Molbio Pvt. Ltd.

More speakers to be announced

10:00 – 11:00 | Parallel sessions

Room Sydney

Moderator: N.N.

Speakers:
Andreas Diacon, TASK
Glenn Dale, BioVersys AG

More speakers to be announced

Room Singapore

Moderator: Robert Leo Skov, ESCMID

Speakers:
Sibyl Anthierens, University of Utrecht
Alexander Krause, bioMérieux
Akhil Bansal, AMR Funding Circle
Holger Rohde, Hamburg University Hospital

Room Osaka/Samarkand

Moderator: Peter Beyer, GARDP

Speakers:
Ismael Maatouk, World Health Organization
Usman Nakakana, Bill and Melinda Gates Foundation
Teri Roberts, GARDP

11:00 – 11:30 | Poster presentations

11:30 – 12:30 | Plenary session | Room Sydney

Moderator: Stephanie Buurman, F. Hoffmann-La Roche Ltd

Speakers:
Aleksandar Danilovski, DALISCO d.o.o.
Herbert Wetli, GARDP
Gabriela Henriques, Centre for Process Innovation Ltd
Carmen Coxon, Medicines & Healthcare products
Regulatory Agency UK

12:30 – 14:00 | Lunch break

14:00 – 15:00 | Parallel sessions

Room Sydney

Moderator: Lotte Steuten, Office of Health Economics

Speakers:
Pol Vandenbroucke, Shionogi
Wolfgang Philipp, European Commission
Jasper Claessen, Dutch Ministry of Health

More speakers to be announced

Room Singapore

Moderator: Caline Mattar, Global AMR R&D Hub

Speakers:
Jomana Musmar, US Presidential Advisory Council on Combating Antibiotic Resistant Bacteria
Yewande Alimi, Africa Centres for Disease Control and Prevention
Aula Abbara, Imperial College London
Sarah Tschudin-Sutter, Basel University Hospital

Supported by

Room Osaka/Samarkand

Moderator: Rienk Pypstra, tranScrip

Speakers:
Radu Botgros, European Medicines Agency
Marc Bonten,European
Clinical Research Alliance on Infectious Diseases
Peter Kim, U.S. Food & Drug Administration

More speakers to be announced

15:30 – 16:30 | Parallel sessions

Room Sydney

Moderator: Sina Gerbach, INCATE

Speakers:
Astrid Pentz-Murr, GARDP
Patrice Courvalin, ICARe
Taslimarif Saiyed, CCAMP
Richard Alm, CARB-X

Room Singapore

Moderator: Toby Leslie, Fleming Fund

Speakers:
Alexandra Cameron, World Health Organization
Megan Neary, Wellcome Trust
Kristina Osbjer, International Centre for Antimicrobial Resistance Solutions

More speakers to be announced

Room Osaka/Samarkand

Moderator: Remko van Leeuwen, SurvivX

Speakers:
Zhenkun Ma, TenNor Therapeutics
Cédric Govaerts, Santero Therapeutics
Philippe Herman,  Immunochem
Alireza Shamaei-tousi, Debiopharm

16:45 – 17:00 | Plenary session | Room Sydney

Moderator: N.N.

17:00 – 18:00 | Plenary session | Room Sydney

Moderator: Diane Shader Smith, Global AMR Diary

Speakers:
Kate Grailey, Imperial College London
Becky McCall, University College London
Francesca Chiara, AMR Narrative

18:00 – 19:00 | Farewell reception

BEAM Alliance program committee

Marc Gitzinger

CEO, BioVersys AG & President, BEAM Alliance

Florence Séjourné

CEO, Aurobac Therapeutics & Treasurer, BEAM Alliance

Deepali Patel

Director of international policy, AMR Action Fund